My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 370

    1.

    Cardiac abnormalities in diabetic patients with neuropathy: effects of aldose reductase inhibitor administration.

    Johnson BF, Nesto RW, Pfeifer MA, Slater WR, Vinik AI, Chyun DA, Law G, Wackers FJ, Young LH.

    Diabetes Care. 2004 Feb;27(2):448-54.PMID: 14747227 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Left ventricular systolic and diastolic function in normotensive type 1 diabetic patients with or without autonomic neuropathy: a radionuclide ventriculography study.

    Didangelos TP, Arsos GA, Karamitsos DT, Athyros VG, Karatzas ND.

    Diabetes Care. 2003 Jul;26(7):1955-60.PMID: 12832295 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Myocardial dysfunction and adrenergic cardiac innervation in patients with insulin-dependent diabetes mellitus.

    Scognamiglio R, Avogaro A, Casara D, Crepaldi C, Marin M, Palisi M, Mingardi R, Erle G, Fasoli G, Dalla Volta S.

    J Am Coll Cardiol. 1998 Feb;31(2):404-12.PMID: 9462586 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effects of ponalrestat, an aldose reductase inhibitor, on neutrophil killing of Escherichia coli and autonomic function in patients with diabetes mellitus.

    Boland OM, Blackwell CC, Clarke BF, Ewing DJ.

    Diabetes. 1993 Feb;42(2):336-40.PMID: 8425670 [PubMed - indexed for MEDLINE]Related articles

    5.

    One-year treatment with the aldose reductase inhibitor, ponalrestat, in diabetic neuropathy.

    Ziegler D, Mayer P, Rathmann W, Gries FA.

    Diabetes Res Clin Pract. 1991 Oct;14(1):63-73.PMID: 1748064 [PubMed - indexed for MEDLINE]Related articles

    6.

    The effect of an aldose reductase inhibitor on cardiovascular performance in patients with diabetes mellitus.

    Roy TM, Broadstone VL, Peterson HR, Snider HL, Cyrus J, Fell R, Rothchild AH, Samols E, Pfeifer MA.

    Diabetes Res Clin Pract. 1990 Aug-Sep;10(1):91-7.PMID: 2123430 [PubMed - indexed for MEDLINE]Related articles

    7.

    Cardiac sympathetic neuropathy and effects of aldose reductase inhibitor in streptozotocin-induced diabetic rats.

    Kurata C, Okayama K, Wakabayashi Y, Shouda S, Mikami T, Tawarahara K, Sugiyama T.

    J Nucl Med. 1997 Nov;38(11):1677-80.PMID: 9374332 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Clinical efficacy of fidarestat, a novel aldose reductase inhibitor, for diabetic peripheral neuropathy: a 52-week multicenter placebo-controlled double-blind parallel group study.

    Hotta N, Toyota T, Matsuoka K, Shigeta Y, Kikkawa R, Kaneko T, Takahashi A, Sugimura K, Koike Y, Ishii J, Sakamoto N; SNK-860 Diabetic Neuropathy Study Group.

    Diabetes Care. 2001 Oct;24(10):1776-82. Erratum in: Diabetes Care 2002 Feb;25(2):413-4. PMID: 11574441 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study.

    Sasso FC, Carbonara O, Cozzolino D, Rambaldi P, Mansi L, Torella D, Gentile S, Turco S, Torella R, Salvatore T.

    J Am Coll Cardiol. 2000 Jul;36(1):219-26.PMID: 10898438 [PubMed - indexed for MEDLINE]Related articles

    10.

    Autonomic influence on cardiovascular performance in diabetic subjects.

    Roy TM, Peterson HR, Snider HL, Cyrus J, Broadstone VL, Fell RD, Rothchild AH, Samols E, Pfeifer MA.

    Am J Med. 1989 Oct;87(4):382-8.PMID: 2801728 [PubMed - indexed for MEDLINE]Related articles

    11.

    Effects of oral amino acid supplementation on myocardial function in patients with type 2 diabetes mellitus.

    Scognamiglio R, Negut C, Piccolotto R, Dioguardi FS, Tiengo A, Avogaro A.

    Am Heart J. 2004 Jun;147(6):1106-12.PMID: 15199363 [PubMed - indexed for MEDLINE]Related articles

    12.

    Effects of sorbinil therapy in diabetic patients with painful peripheral neuropathy and autonomic neuropathy.

    Jaspan JB, Herold K, Bartkus C.

    Am J Med. 1985 Nov 15;79(5A):24-37.PMID: 3000176 [PubMed - indexed for MEDLINE]Related articles

    13.

    Comparison of left ventricular function in insulin- and non-insulin-dependent diabetes mellitus.

    Ferraro S, Perrone-Filardi P, Maddalena G, Desiderio A, Gravina E, Turco S, Chiariello M.

    Am J Cardiol. 1993 Feb 15;71(5):409-14.PMID: 8430628 [PubMed - indexed for MEDLINE]Related articles

    14.

    Peripheral and autonomic nerve function in 259 diabetic patients with peripheral neuropathy treated with ponalrestat (an aldose reductase inhibitor) or placebo for 18 months. United Kingdom/Scandinavian Ponalrestat Trial.

    Sundkvist G, Armstrong FM, Bradbury JE, Chaplin C, Ellis SH, Owens DR, Rosén I, Sönksen P.

    J Diabetes Complications. 1992 Apr-Jun;6(2):123-30.PMID: 1611136 [PubMed - indexed for MEDLINE]Related articles

    15.

    Clinical studies with an aldose reductase inhibitor in the autonomic and somatic neuropathies of diabetes.

    Jaspan JB, Towle VL, Maselli R, Herold K.

    Metabolism. 1986 Apr;35(4 Suppl 1):83-92.PMID: 3083212 [PubMed - indexed for MEDLINE]Related articles

    16.

    Aldose reductase inhibition ameliorates pupillary light reflex and F-wave latency in patients with mild diabetic neuropathy.

    Nakayama M, Nakamura J, Hamada Y, Chaya S, Mizubayashi R, Yasuda Y, Kamiya H, Koh N, Hotta N.

    Diabetes Care. 2001 Jun;24(6):1093-8.PMID: 11375376 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Systolic and diastolic left ventricular dysfunction in middle-aged asymptomatic non-insulin-dependent diabetics.

    Yasuda I, Kawakami K, Shimada T, Tanigawa K, Murakami R, Izumi S, Morioka S, Kato Y, Moriyama K.

    J Cardiol. 1992;22(2-3):427-38.PMID: 1339801 [PubMed - indexed for MEDLINE]Related articles

    18.

    Uncomplicated type 1 diabetes and preclinical left ventricular myocardial dysfunction: insights from echocardiography and exercise cardiac performance evaluation.

    Palmieri V, Capaldo B, Russo C, Iaccarino M, Pezzullo S, Quintavalle G, Di Minno G, Riccardi G, Celentano A.

    Diabetes Res Clin Pract. 2008 Feb;79(2):262-8. Epub 2007 Nov 8.PMID: 17996323 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effects of mental stress on left ventricular and peripheral vascular performance in patients with coronary artery disease.

    Jain D, Shaker SM, Burg M, Wackers FJ, Soufer R, Zaret BL.

    J Am Coll Cardiol. 1998 May;31(6):1314-22.PMID: 9581726 [PubMed - indexed for MEDLINE]Related articles

    20.

    Attenuation of ischemia induced increases in sodium and calcium by the aldose reductase inhibitor zopolrestat.

    Ramasamy R, Liu H, Oates PJ, Schaefer S.

    Cardiovasc Res. 1999 Apr;42(1):130-9.PMID: 10435004 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity